Effectiveness of early heparin therapy on outcomes in critically ill patients with sepsis-induced coagulopathy
Frontiers in Pharmacology · 15.05.2023 · 14
DOI: 10.3389/fphar.2023.1173893 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 15.05.2023. Verfasst von Jia-Jia Huang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infection and Critical Care Medicine, Health Science Center, Shenzhen Second People's Hospital and First Affiliated Hospital of Shenzhe…. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sanming Project of Medicine in Shenzhen, Science, Technology and Innovation Commission of Shenzhen Municipality.
Themen: Sepsis
Abstract (Originalsprache)
Background
This study aimed to investigate whether early unfractionated heparin (UFH) administration provides a survival advantage for patients with sepsis-induced coagulopathy (SIC).
Methods
Patients hospitalized with sepsis-induced coagulopathy from the Medical Information Mart for Intensive Care (MIMIC)-IV database were identified. Patients were divided into two groups, who received unfractionated heparin (UFH) subcutaneously within 24 h after intensive care unit (ICU) admission, and the control group, who received not. The primary endpoint was intensive care unit mortality, the secondary outcomes were 7, 14, and 28-day and hospital mortality. Propensity score matching (PSM) the marginal structural Cox model (MSCM) and E-value analysis were used to account for baseline differences, time-varying and unmeasured confounding factors.
Results
A total of 3,377 patients with sepsis-induced coagulopathy were enrolled in the study, of which 815 in unfractionated heparin group and 2,562 in control group. There was significant effect on primary and secondary outcomes with unfractionated heparin after propensity score matching (intensive care unit mortality, hazard ratio [HR] 0.69, 95% confidence interval [CI] 0.52–0.92; 7-day, HR 0.70, 95% CI 0.49–0.99; 14-day, HR 0.68.95% CI 0.50–0.92; 28-day, HR 0.72, 95% CI 0.54–0.96; hospital mortality, HR 0.74, 95% CI 0.57–0.96), marginal structural Cox model manifested unfractionated heparin associated with decreased intensive care unit mortality in all populations (HR 0.64, 95% CI 0.49–0.84), and stratification with the marginal structural Cox model indicated analysis further indicated the survival advantage only among patients with an sepsis-induced coagulopathy score of 4 (HR 0.56, 95% CI 0.38–0.81). Further analysis showed that treatment with 6,250–13750 IU/day of unfractionated heparin associated with a decreased risk of intensive care unit mortality. Similar results were replicated in subgroup analysis with propensity score matching only for patients with an sepsis-induced coagulopathy score of 4 (intensive care unit mortality, HR 0.51, 95% CI 0.34–0.76).
Conclusion
This study found early unfractionated heparin therapy to patients with sepsis-induced coagulopathy appears to be associated with improved outcomes. Subgroup analysis further demonstrates heparin therapy decreased intensive care unit mortality primarily in patients only with SIC score of 4.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Infection and Critical Care Medicine, Health Science Center, Shenzhen Second People's Hospital and First Affiliated Hospital of Shenzhen University, Shenzhen, China.
- Postgraduate Education, Shantou University Medical College, Shantou, China.
- Department of Critical Care Medicine, Pingshan District People's Hospital of Shenzhen, Shenzhen, China.
- Department of Central Laboratory, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing, China.
- Trauma Research Center, Medical Innovation Research Department and Fourth Medical Center of the Chinese PLA General Hospital, Beijing, China.
- Department of Nosocomial Infection Prevention and Control, Shenzhen Second People's Hospital, Shenzhen, China.
Förderung
- Sanming Project of Medicine in Shenzhen
- Science, Technology and Innovation Commission of Shenzhen Municipality
Zitieren
APA
Huang, J. J., Zou, Z. Y., Zhou, Z. P., Liu, Y., Yang, Z. J., Zhang, J. J., Luan, Y. Y., Yao, Y. M., & Wu, M. (2023). Effectiveness of early heparin therapy on outcomes in critically ill patients with sepsis-induced coagulopathy. Frontiers in Pharmacology, 14. https://doi.org/10.3389/fphar.2023.1173893
Vancouver
Huang JJ, Zou ZY, Zhou ZP, Liu Y, Yang ZJ, Zhang JJ, et al. Effectiveness of early heparin therapy on outcomes in critically ill patients with sepsis-induced coagulopathy. Frontiers in Pharmacology. 2023;14. doi:10.3389/fphar.2023.1173893
BibTeX
@article{Huang2023,
author = {Huang, Jia-Jia and Zou, Zhi-Ye and Zhou, Zhi-Peng and Liu, Yan and Yang, Zhen-Jia and Zhang, Jing-Jing and Luan, Ying-Yi and Yao, Yong-Ming and Wu, Ming},
title = {Effectiveness of early heparin therapy on outcomes in critically ill patients with sepsis-induced coagulopathy},
journal = {Frontiers in Pharmacology},
year = {2023},
volume = {14},
doi = {10.3389/fphar.2023.1173893}
}
EUVIMED